Dr. LaVange has a broad background in the biostatistics field, including leadership roles in industry (RTI, Quintiles, Inspire Pharmaceuticals); academia (UNC/CSCC); and government (Center for Drug Evaluation and Research at the FDA). She was also the 2018 president of the American Statistical Association. At the CSCC, she has been the lead PI on the HCHS/SOL and SPIROMICS studies, and is currently the Coordinating Center PI for the Adolescent Medicine Trials Network for HIV/AIDS Intervention (ATN) and co-PI of the Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network (PrecISE).